|
ZNF682 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.938300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.195760E-02 |
| Normal-vs-Stage2 |
2.935600E-01 |
| Normal-vs-Stage3 |
9.971000E-01 |
| Normal-vs-Stage4 |
3.145200E-01 |
| Stage1-vs-Stage2 |
9.759600E-01 |
| Stage1-vs-Stage3 |
3.471700E-02 |
| Stage1-vs-Stage4 |
7.733600E-01 |
| Stage2-vs-Stage3 |
3.065000E-01 |
| Stage2-vs-Stage4 |
8.643400E-01 |
| Stage3-vs-Stage4 |
3.329800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.826300E-02 |
| Normal-vs-AfricanAmerican |
1.438770E-01 |
| Normal-vs-Asian |
2.483200E-03 |
| Caucasian-vs-AfricanAmerican |
8.764800E-03 |
| Caucasian-vs-Asian |
2.341900E-02 |
| AfricanAmerican-vs-Asian |
3.009800E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.983000E-04 |
| Normal-vs-Female |
5.061800E-01 |
| Male-vs-Female |
8.590500E-04 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.499500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.317400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.448000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.199800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.140400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.772600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.063000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.317600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.875800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.217000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.13619999999137E-05 |
| Classical-VS-Follicular |
9.660000E-01 |
| Classical-VS-Other |
2.473200E-01 |
| Classical-VS-Normal |
2.111900E-02 |
| Tall-VS-Follicular |
8.781300E-04 |
| Tall-VS-Other |
1.142780E-01 |
| Tall-VS-Normal |
2.290100E-02 |
| Follicular-VS-Other |
2.475400E-01 |
| Follicular-VS-Normal |
1.092350E-01 |
| Other-VS-Normal |
1.769400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.098400E-02 |
| Normal-vs-N1 |
2.798300E-02 |
| N0-vs-N1 |
1.955380E-01 |
|
|
